INNMF Company Profile and Key Details

Q: Who are the executives of INNMF?

Mr. Andrew John Cooke FAICS, FCIS, FGIA, L.L.B., LLB, MAICDCompany Sec.Dr. Frank GelderFounding ScientistDr. James A. Taylor Ph.D.Trials ConsultantDr. Christopher J. Burns B.Sc., BSc(Hons), Ph.D.Chief Executive Officer, MD & DirectorMs. Rhiannon Jones B.Sc., Ph.D.Chief Operating OfficerDr. Michael H. Silverman B.Sc., M.B.A., M.D., F.A.C.P., FACRTrials ConsultantDr. Benjamin M. SegalClinical ConsultantDr. Frederick E. Reno Ph.D.Toxicology ConsultantMr. Hamish GeorgeChief Financial OfficerMs. Terrie-Anne Cock Ph.D.Head of Translational Biology

PNK : INNMF

Amplia Therapeutics

$0.05

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Amplia Therapeutics Limited (INNMF) stock remained unchanged at $0.09 a share on OTC. The stock opened at $0.10, fluctuating between $0.09 to $0.10 during the session.

Stock Snapshot

0.09

Prev. Close

46.2M

Market Cap

0.09

Day Low

-8.14

P/E Ratio

-0.01105

EPS (TTM)

-0.04

Cash Flow per Share

0.1

Open

513.31M

Number of Shares

0.1

Day High

92.87%

Free Float in %

0.07

Book Value

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 10, 2026	0.09	0.09	0.09	0.09	23K
Sep 09, 2026	0.10	0.10	0.10	0.10	28.05K
Sep 04, 2026	0.10	0.10	0.10	0.10	40K
Sep 03, 2026	0.10	0.10	0.10	0.10	20.93K
Sep 02, 2026	0.10	0.10	0.09	0.09	4K
Sep 01, 2026	0.10	0.10	0.10	0.10	750
Aug 31, 2026	0.10	0.10	0.10	0.10	11K
Aug 26, 2026	0.11	0.11	0.11	0.11	250
Aug 21, 2026	0.11	0.11	0.11	0.11	20K
Aug 19, 2026	0.11	0.11	0.11	0.11	2.3K
Aug 18, 2026	0.11	0.12	0.11	0.12	7K
Aug 17, 2026	0.07	0.12	0.07	0.11	215.56K
Aug 14, 2026	0.11	0.11	0.11	0.11	30.8K
Aug 12, 2026	0.10	0.10	0.09	0.10	9K
Aug 10, 2026	0.11	0.11	0.10	0.10	6.09K
Aug 07, 2026	0.09	0.11	0.09	0.11	12.17K
Aug 06, 2026	0.10	0.11	0.10	0.11	3K
Aug 05, 2026	0.09	0.09	0.09	0.09	5K
Aug 04, 2026	0.11	0.12	0.11	0.11	181.3K
Aug 03, 2026	0.10	0.10	0.09	0.09	50K

Contact Details

Melbourne, VIC 3000

Australia

https://www.ampliatx.com 613 912 31140

About Company

Established in 2000 and headquartered in Melbourne, Australia, Amplia Therapeutics Limited is a pharmaceutical firm dedicated to the discovery and development of focal adhesion kinase (FAK) inhibitors. The company's therapeutic endeavors are concentrated on oncology (cancer) and chronic fibrotic diseases. Its drug development pipeline includes AMP945, a FAK inhibitor that has successfully completed Phase I clinical trials and is being explored for its efficacy in treating pancreatic cancer, idiopathic pulmonary fibrosis, and a broader spectrum of cancerous and fibrotic conditions. Another compound, AMP886, is also under development for potential applications in cancer and fibrotic disorders. Amplia Therapeutics maintains a strategic collaboration with the Garvan Institute of Medical Research in Sydney, and the company adopted its current name in September 2018, having previously operated as Innate Immunotherapeutics Limited.

Stock Peers

LZAGF

-5-0.92%

Lonza Group AG$541.00 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 LZAGY

-0.33-0.61%

Lonza Group AG$53.87 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 GRTX

1.53+9.80%

Galera Therapeutics, Inc.$17.15 NURPF

Neuren Pharmaceuticals Limited$14.00

Frequently Asked Questions

What is the current Amplia Therapeutics Limited (INNMF) stock price?

Amplia Therapeutics Limited (OTC: INNMF) stock price is $0.09 in the last trading session. During the trading session, INNMF stock reached the peak price of $0.10 while $0.09 was the lowest point it dropped to. The percentage change in INNMF stock occurred in the recent session was 0% while the dollar amount for the price change in INNMF stock was $0.00.

INNMF's industry and sector of operation?

The OTC listed INNMF is part of Biotechnology industry that operates in the broader Healthcare sector. Amplia Therapeutics Limited designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of INNMF?

Mr. Andrew John Cooke FAICS, FCIS, FGIA, L.L.B., LLB, MAICD
Company Sec.
Dr. Frank Gelder
Founding Scientist
Dr. James A. Taylor Ph.D.
Trials Consultant
Dr. Christopher J. Burns B.Sc., BSc(Hons), Ph.D.
Chief Executive Officer, MD & Director
Ms. Rhiannon Jones B.Sc., Ph.D.
Chief Operating Officer
Dr. Michael H. Silverman B.Sc., M.B.A., M.D., F.A.C.P., FACR
Trials Consultant
Dr. Benjamin M. Segal
Clinical Consultant
Dr. Frederick E. Reno Ph.D.
Toxicology Consultant
Mr. Hamish George
Chief Financial Officer
Ms. Terrie-Anne Cock Ph.D.
Head of Translational Biology

How INNMF did perform over past 52-week?

INNMF's closing price is 102.8% higher than its 52-week low of $0.05 where as its distance from 52-week high of $0.27 is -36.62%.

How many employees does INNMF have?

Number of INNMF employees currently stands at 1.

Link for INNMF official website?

Official Website of INNMF is: https://www.ampliatx.com

How do I contact INNMF?

INNMF could be contacted at phone 613 912 31140 and can also be accessed through its website. INNMF operates from 90 William Street, Melbourne, VIC 3000, Australia.

How many shares of INNMF are traded daily?

INNMF stock volume for the day was 8K shares. The average number of INNMF shares traded daily for last 3 months was 14.19K.

What is the market cap of INNMF currently?

The market value of INNMF currently stands at $46.20M with its latest stock price at $0.09 and 513.31M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	1
Beta	-0.4
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	March
Sector	Healthcare
Industry	Biotechnology

Employees	1
Beta	-0.4
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	March
Sector	Healthcare
Industry	Biotechnology

INNMF Company Profile and Key Details

Amplia Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Dividend & Fair Value

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Price Forecast & Outlook

Key Takeaways

Valuation Metrics